Considering these inconsistent results, we conducted a meta-analysis to evaluate whether CSF Aβ42, t-tau, and p-tau levels are of value in the differential diagnosis of iNPH from AD and healthy normal controls. The gene discussed is MAPT; the disease is Alzheimer disease.